ACE2 and COVID-19: Early mouse models recapitulated only mild patterns of COVID-19 disease [14,15], but the development of humanized angiotensin-converting enzyme 2 (ACE2) transgenic mice allowed the study of more severe SARS-CoV-2 pulmonary infections [15].